JP Stock MarketDetailed Quotes

2370 Medinet

Watchlist
  • 32
  • 00.00%
20min DelayTrading Apr 25 09:51 JST
8.47BMarket Cap-6.35P/E (Static)

About Medinet Company

Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Company Profile

Symbol2370
Company NameMedinet
Founded1995-10-17
MarketTSE Growth
Fiscal Year Ends09-30
Address1-1 Heiwajima 6-chome 9th Floor, TRC Center Building
Zip Code143-0006
Phone03-6631-1201

Company Executives

  • Name
  • Position
  • Salary
  • Yoshiji Kimura
  • Chairman of the Board
  • --
  • Kubushira Kanenao
  • President and Chief Executive Director
  • --
  • Masami Ochiai
  • Director of Business Management
  • --
  • Kondo Takashige
  • Director, Cell Processing Division
  • --
  • Takeshi Shinoda
  • Independent Director
  • --
  • Kunihide Ichikawa
  • Independent Director
  • --
  • Koichiro Yoshino
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More